export interface ClinicalStrategyEntry {
  id: string;
  name: string;
  etymology: string;
  aliases: string[];
  definition: string;
  details: string[];
  boardsPearls: string[];
  pediatrics?: string;
}

export const CLINICAL_STRATEGIES: ClinicalStrategyEntry[] = [
  {
    id: "rate-control",
    name: "Rate control",
    etymology: "rate = ventricular beats per minute + control = restraint/regulation",
    aliases: ["rate control", "rate-control"],
    definition:
      "Management strategy for atrial fibrillation/flutter that limits ventricular response without necessarily restoring sinus rhythm.",
    details: [
      "Goal: adequate ventricular rate (often <110 bpm at rest) and symptom relief while accepting continued AF",
      "First-line agents: β-blockers (metoprolol, atenolol), nondihydropyridine CCBs (diltiazem, verapamil)",
      "Digoxin for rate control (especially with HF or sedentary patients; less effective with exertion)",
      "Dihydropyridine CCBs (amlodipine, nifedipine) are not used for AV nodal rate control",
      "Often preferred in elderly patients and when rhythm-control drugs are high risk",
    ],
    boardsPearls: [
      "Rate control vs rhythm control: similar mortality in many AF patients (AFFIRM trial framework)",
      "WPW + AF: avoid AV nodal blockers (β-blocker, nondihydropyridine CCB, digoxin) → use procainamide or cardioversion",
      "Nondihydropyridine CCB + β-blocker → additive bradycardia/AV block",
      "Amiodarone can provide both rate and rhythm control but is not first-line for rate-only strategy",
    ],
    pediatrics:
      "Rate control in pediatric AF/SVT uses weight-based β-blockers or digoxin; same AV nodal physiology applies.",
  },
  {
    id: "rhythm-control",
    name: "Rhythm control",
    etymology: "Greek rhythmos = measured flow/beat + control = restraint/regulation",
    aliases: ["rhythm control", "rhythm-control"],
    definition:
      "Management strategy for atrial fibrillation/flutter aimed at restoring and maintaining sinus rhythm.",
    details: [
      "Goal: cardioversion to sinus rhythm and prevention of AF recurrence",
      "Electrical cardioversion or chemical cardioversion (antiarrhythmics)",
      "Rhythm-control drugs: amiodarone, flecainide, propafenone, sotalol, dofetilide (patient- and substrate-specific)",
      "Anticoagulate ≥3 weeks before elective cardioversion if AF >48 h or duration unknown, or perform TEE to exclude LA thrombus",
      "May be preferred in symptomatic younger patients, tachycardia-mediated cardiomyopathy, or difficult rate control",
    ],
    boardsPearls: [
      "Cardioversion without anticoagulation if AF <48 h and low thromboembolic risk — otherwise anticoagulate or TEE first",
      "Flecainide/propafenone — avoid in structural heart disease or CAD (proarrhythmia risk)",
      "Amiodarone effective for rhythm control but long-term toxicity limits use",
      "Rhythm control does not consistently outperform rate control for survival — anticoagulation still required by stroke risk",
    ],
    pediatrics:
      "Rhythm control in children often involves cardioversion for hemodynamically significant AF; antiarrhythmic choice is specialist-guided.",
  },
  {
    id: "squatting",
    name: "Squatting",
    etymology: "squat = crouched posture; increases systemic vascular resistance",
    aliases: ["squatting", "squatting maneuver", "squats"],
    definition:
      "Physical maneuver that increases systemic vascular resistance (SVR) and venous return; used instinctively by children with tetralogy of Fallot during hypercyanotic spells.",
    details: [
      "↑ SVR → ↑ systemic afterload → favors left-to-right flow or reduces right-to-left shunt across VSD",
      "In ToF tet spell: squatting ↑ SVR, ↓ R→L shunt, improves pulmonary blood flow and oxygenation",
      "Opposite of Valsalva/standing in HOCM (which ↓ preload and worsens LVOT obstruction)",
      "Knee-chest position in infants provides similar ↑ SVR effect",
    ],
    boardsPearls: [
      "Child with cyanosis who squats → think tetralogy of Fallot",
      "Squatting ↓ murmur intensity in HOCM (↑ preload) but helps cyanosis in ToF (↑ SVR)",
      "Hypercyanotic spell treatment: knee-chest, O₂, morphine, phenylephrine (↑ SVR), fluids",
    ],
    pediatrics:
      "Toddlers with ToF may assume squatting during play to relieve cyanosis — pathognomonic behavior on boards.",
  },
  {
    id: "valsalva-maneuver",
    name: "Valsalva Maneuver",
    etymology: "eponym: Antonio Maria Valsalva + maneuver = deliberate physical action",
    aliases: [
      "valsalva",
      "valsalva maneuver",
      "valsalva manoeuvre",
      "valsalva strain",
      "bearing down",
      "forced expiration against closed glottis",
    ],
    definition:
      "Physiologic maneuver of forced expiration against a closed glottis (straining/bearing down), transiently raising intrathoracic and intra-abdominal pressure and altering venous return and cardiac murmur intensity.",
    details: [
      "Phase 1: ↑ intrathoracic pressure → brief ↑ arterial pressure",
      "Phase 2: ↓ venous return → ↓ preload → ↓ stroke volume → ↓ blood pressure",
      "Phase 3: further ↓ pressure as strain continues",
      "Phase 4: release → venous return surges → reflex ↑ heart rate and blood pressure",
      "Used clinically to accentuate or diminish heart murmurs and in autonomic testing",
    ],
    boardsPearls: [
      "Valsalva ↓ preload (↓ venous return) — key for murmur differentiation",
      "HOCM murmur ↑ with Valsalva and standing (↓ preload worsens LVOT obstruction)",
      "Aortic stenosis murmur ↓ with Valsalva (less stroke volume across stenotic valve)",
      "Most other murmurs (MR, VSD, AR) ↓ with Valsalva because ↓ preload",
      "Squatting ↑ preload — opposite effect; HOCM murmur ↓ with squatting",
      "Prolonged Valsalva during labor, heavy lifting, or defecation can provoke syncope",
      "Used in autonomic testing — abnormal HR/BP response suggests dysautonomia",
    ],
    pediatrics:
      "Same hemodynamic principles apply; HOCM and ToF boards questions use squatting vs Valsalva/standing as opposing maneuvers.",
  },
  {
    id: "titrate",
    name: "Titrate",
    etymology: "Latin titulus = measured mark → titrate = adjust in measured steps",
    aliases: [
      "titrate",
      "titrates",
      "titrating",
      "titrated",
      "titration",
      "dose titration",
      "dose titrate",
      "titrate dose",
      "titrate medication",
    ],
    definition:
      "Incremental adjustment of medication dose (or infusion rate) based on clinical response, vital signs, or laboratory targets until efficacy is achieved without unacceptable toxicity.",
    details: [
      "Start low (or weight-based loading when indicated), then increase or decrease in stepwise fashion",
      "Recheck interval depends on drug half-life and risk (e.g., levothyroxine every 6–8 weeks; insulin daily)",
      "Used when therapeutic window is narrow or response is highly individual",
      "Opposite of fixed one-size dose when patient factors dominate (renal function, weight, sensitivity)",
    ],
    boardsPearls: [
      "Titrate levothyroxine to normalize TSH in hypothyroidism",
      "Titrate warfarin to target INR; bridge with heparin when initiating",
      "Titrate insulin to glucose targets in diabetes",
      "Titrate diuretics in heart failure to euvolemia without hypotension or renal injury",
      "vs titer — titrate = adjust dose; titer = antibody dilution endpoint on serology",
      "Start low, go slow for drugs with delayed steady state (levothyroxine, amiodarone)",
    ],
    pediatrics:
      "Pediatric dosing is weight-based and often titrated (levothyroxine in congenital hypothyroidism, insulin in type 1 diabetes); growth and puberty change requirements over time.",
  },
  {
    id: "migraine-prophylaxis",
    name: "Migraine prophylaxis",
    etymology: "Greek hēmi = half + kranion = skull (migraine) + Greek prophylaxis = guard before",
    aliases: [
      "migraine prophylaxis",
      "migraine prevention",
      "preventive migraine therapy",
      "migraine prophylactic therapy",
      "prophylactic migraine treatment",
    ],
    definition:
      "Preventive pharmacologic strategy to reduce migraine attack frequency, severity, and disability in patients with recurrent or disabling migraines — distinct from abortive (acute) treatment.",
    details: [
      "Indicated when migraines are frequent (often ≥4 headache days/month), prolonged, or cause significant disability despite abortive therapy",
      "First-line agents (Step 1 favorites): β-blockers (propranolol, metoprolol), anticonvulsants (topiramate, valproate), tricyclic antidepressants (amitriptyline)",
      "Other options: calcium channel blockers (verapamil for cluster overlap; less first-line for migraine), CGRP monoclonal antibodies (more Step 2/3 detail)",
      "Requires weeks of daily dosing before benefit; continue 3–6 months after good control before taper trial",
      "Avoid β-blockers in asthma/COPD (use cardioselective agents cautiously or choose non-β-blocker); valproate teratogenic — avoid in pregnancy",
      "Lifestyle: sleep regularity, hydration, trigger avoidance complement pharmacotherapy",
    ],
    boardsPearls: [
      "Prophylaxis = daily prevention; abortive = treat acute attack (triptans, NSAIDs, antiemetics)",
      "Propranolol, topiramate, amitriptyline, valproate — classic migraine prophylaxis list",
      "β-blocker side effects: bradycardia, bronchospasm, fatigue, masked hypoglycemia",
      "Topiramate: weight loss, paresthesias, cognitive slowing; teratogenic risk",
      "Do not use triptans for prophylaxis — they are acute abortive agents",
    ],
    pediatrics:
      "Pediatric migraine prophylaxis uses weight-based topiramate, propranolol, or amitriptyline when attacks are frequent/disabling; behavioral therapy and lifestyle measures are first-line in many children before daily medication.",
  },
  {
    id: "hundred-percent-oxygen",
    name: "100% Oxygen",
    etymology: "Latin centum = hundred + Latin per = through + centum + oxygen = O₂ gas",
    aliases: [
      "100% oxygen",
      "100 percent oxygen",
      "high flow oxygen",
      "high-flow oxygen",
      "normobaric oxygen therapy",
      "oxygen therapy cluster headache",
      "non-rebreather oxygen",
      "non rebreather mask oxygen",
    ],
    definition:
      "Inhalation of high-concentration oxygen (typically 12–15 L/min via non-rebreather mask) — first-line acute abortive therapy for cluster headache and used in selected hypoxemic emergencies.",
    details: [
      "Cluster headache: 12–15 L/min 100% O₂ via non-rebreather mask for 15–20 minutes at attack onset",
      "Mechanism in cluster headache likely involves carotid body chemoreceptor modulation and trigeminovascular pathway effects",
      "Also used in carbon monoxide poisoning, decompression sickness, and preoxygenation before intubation",
      "Non-rebreather mask delivers highest FiO₂ without mechanical ventilation",
      "Does not replace sumatriptan when oxygen unavailable — sumatriptan SC is alternative acute cluster therapy",
    ],
    boardsPearls: [
      "Cluster headache acute treatment: 100% oxygen OR sumatriptan SC",
      "O₂ at 12–15 L/min non-rebreather for 15–20 min — classic boards answer",
      "vs migraine abortive — triptans/NSAIDs for migraine; oxygen is cluster-specific acute therapy",
      "Cluster headache: unilateral periorbital pain + autonomic symptoms (lacrimation, rhinorrhea, ptosis)",
      "Verapamil is cluster prophylaxis — not acute abortive like oxygen",
    ],
    pediatrics:
      "Cluster headache is rare in children; same oxygen protocol applies when diagnosed. Use caution with high-flow oxygen in infants — specialist-guided.",
  },
  {
    id: "fundal-height",
    name: "Fundal Height",
    etymology: "Latin fundus = bottom/base (uterine top) + Old English hiehthu = height",
    aliases: [
      "fundal height",
      "fundal heights",
      "uterine fundal height",
      "symphysis-fundal height",
      "sfh",
    ],
    definition:
      "Clinical measurement from the superior border of the symphysis pubis to the uterine fundus with a tape measure; used to estimate gestational age and screen for abnormal fetal growth or amniotic fluid volume.",
    details: [
      "Measured with patient supine, bladder empty, uterus not contracted",
      "After ~12–14 weeks the uterus rises out of the pelvis; fundal height becomes clinically useful",
      "From ~20 to 36 weeks gestation: fundal height in centimeters approximates gestational age in weeks (±2–3 cm)",
      "Fundal height below dates → IUGR, oligohydramnios, fetal anomaly, wrong dates",
      "Fundal height above dates → macrosomia, polyhydramnios, multifetal pregnancy, wrong dates",
      "Less reliable with obesity, fibroids, fetal malposition, or hydramnios",
    ],
    boardsPearls: [
      "SFH in cm ≈ gestational weeks (20–36 weeks) — classic boards approximation",
      "Small for dates → consider IUGR, oligohydramnios (Potter sequence association), chromosomal abnormality",
      "Large for dates → gestational diabetes/macrosomia, polyhydramnios (e.g., fetal GI atresia, diabetes, anencephaly with open neural tube)",
      "Confirm discrepancies with ultrasound biometry and amniotic fluid index",
      "vs abdominal girth — fundal height is symphysis-to-fundus linear measure, not abdominal circumference",
    ],
    pediatrics:
      "Fundal height tracks in utero fetal growth; after birth, length/weight/head circumference percentiles replace SFH for growth monitoring.",
  },
  {
    id: "apgar-score",
    name: "APGAR Score",
    etymology: "eponym: Virginia Apgar + score = numerical rating",
    aliases: [
      "apgar",
      "apgar score",
      "apgar scores",
      "apgar scoring",
      "apgar assessment",
      "apgar test",
      "apgar evaluation",
    ],
    definition:
      "Rapid bedside assessment of newborn transition at 1 and 5 minutes after birth, scoring five parameters (0–2 each) to identify infants needing resuscitation or ongoing support.",
    details: [
      "A — Appearance (skin color): 2 pink all over; 1 pink body, blue extremities; 0 pale/blue all over",
      "P — Pulse (heart rate): 2 >100 bpm; 1 <100 bpm; 0 absent",
      "G — Grimace (reflex irritability): 2 cough/sneeze/cry with stimulation; 1 grimace only; 0 no response",
      "A — Activity (muscle tone): 2 active motion; 1 some flexion; 0 limp/flaccid",
      "R — Respiration: 2 strong cry; 1 weak/irregular; 0 absent",
      "Total score 0–10; recorded at 1 minute and 5 minutes (and at 10/20 minutes if <7 at 5 minutes)",
      "Score <7 at 5 minutes suggests need for evaluation and possible intervention",
    ],
    boardsPearls: [
      "APGAR mnemonic: Appearance, Pulse, Grimace, Activity, Respiration",
      "1 and 5 minutes — standard timing; not a long-term neurologic outcome predictor alone",
      "Low score at 1 min may improve by 5 min after resuscitation — reassess",
      "Score 0–3 severe distress; 4–6 moderate; 7–10 generally reassuring",
      "vs Silverman-Anderson — respiratory distress scoring in neonates, not whole newborn status",
      "Birth asphyxia workup uses cord gases and neuro exam — APGAR supports but does not define HIE alone",
    ],
    pediatrics:
      "APGAR is a neonatal assessment tool; premature infants may score lower on Activity and Respiration without necessarily indicating poor long-term outcome. Resuscitation follows NRP algorithms independent of waiting for 1-minute score.",
  },
  {
    id: "glycemic-control",
    name: "Glycemic Control",
    etymology: "Greek glykys = sweet + haima = blood + Latin control = restraint/regulation",
    aliases: [
      "glycemic control",
      "glycaemic control",
      "blood glucose control",
      "glucose control",
      "tight glycemic control",
      "glycemic management",
    ],
    definition:
      "Therapeutic strategy to maintain blood glucose near normal range in diabetes mellitus, reducing acute hyperglycemic complications and long-term microvascular and macrovascular injury.",
    details: [
      "Monitored with self-glucose checks, continuous glucose monitoring, and HbA1c (~3-month average glycemia)",
      "Type 1 DM: insulin replacement (basal-bolus or pump) matched to carbohydrate intake and activity",
      "Type 2 DM: lifestyle (diet, exercise, weight loss) plus metformin first-line; add agents per comorbidities (SGLT2i/GLP-1 for CV/renal benefit)",
      "Targets individualized — tighter control in younger patients with short disease duration; less strict in elderly, hypoglycemia-prone, or limited life expectancy",
      "Intensive control delays diabetic nephropathy, retinopathy, and neuropathy but raises hypoglycemia risk",
    ],
    boardsPearls: [
      "HbA1c reflects ~120-day average glucose; goal often <7% in many adults but individualize",
      "Microalbuminuria signals early diabetic nephropathy — glycemic and BP control are renoprotective",
      "Metformin first-line in T2DM; insulin required in T1DM and advanced T2DM",
      "SGLT2 inhibitors and GLP-1 agonists improve outcomes beyond glucose lowering alone",
      "DKA/hypoglycemia are acute risks of poor vs overly aggressive control",
      "vs glycemic monitoring alone — control implies active therapy adjustment, not just measurement",
      "vs lipid/BP control — parallel CV risk reduction, distinct glucose targets",
    ],
    pediatrics:
      "Pediatric T1DM targets slightly higher A1c than adults to limit hypoglycemia-related neurocognitive harm; family-centered insulin regimens and carbohydrate counting are core.",
  },
  {
    id: "cbt",
    name: "Cognitive Behavioral Therapy",
    etymology: "Latin cognoscere = to know + Latin comportare = behave + Greek therapeia = healing",
    aliases: [
      "cbt",
      "cognitive behavioral therapy",
      "cognitive behavioural therapy",
      "cognitive behavior therapy",
      "cognitive-behavioral therapy",
    ],
    definition:
      "Structured psychotherapy targeting maladaptive thoughts (cognitions) and behaviors to reduce psychiatric symptoms and improve functioning — evidence-based for depression, anxiety, PTSD, and adjunctive use in psychosis and adjustment disorders.",
    details: [
      "Cognitive restructuring — identify and challenge distorted automatic thoughts",
      "Behavioral activation — schedule rewarding activities in depression",
      "Exposure and response prevention — OCD and phobias",
      "Skills training — coping, problem-solving, relapse prevention",
      "Time-limited, goal-directed sessions with homework between visits",
    ],
    boardsPearls: [
      "First-line psychotherapy for mild–moderate MDD and anxiety disorders",
      "As effective as SSRIs for many depression/anxiety cases; combined therapy + SSRI for severe depression",
      "CBT for psychosis — adjunct to antipsychotics in delusional disorder and schizophrenia",
      "Adjustment disorder — supportive therapy and CBT preferred over medication initially",
      "vs psychoanalysis — CBT is present-focused, structured, shorter duration",
      "Peds: CBT adapted for children with anxiety, OCD, and depression; family involvement common",
    ],
    pediatrics:
      "Evidence-supported for pediatric anxiety, OCD, and depression; parental involvement and school coordination improve outcomes.",
  },
  {
    id: "glasgow-coma-scale",
    name: "Glasgow Coma Scale",
    etymology: "eponym: Graham Teasdale and Bryan Jennett (Glasgow, Scotland) + coma = deep sleep + Latin scala = ladder",
    aliases: [
      "glasgow coma scale",
      "glasgow coma scales",
      "gcs",
      "glasgow coma score",
      "glasgow coma scores",
    ],
    definition:
      "Standardized 3–15 point clinical score quantifying level of consciousness after brain injury — sums Eye (1–4), Verbal (1–5), and Motor (1–6) responses; lower scores indicate worse impairment.",
    details: [
      "Eye opening: 4 spontaneous, 3 to voice, 2 to pain, 1 none",
      "Verbal: 5 oriented, 4 confused, 3 inappropriate words, 2 incomprehensible sounds, 1 none",
      "Motor: 6 obeys commands, 5 localizes pain, 4 withdraws, 3 abnormal flexion (decorticate), 2 extension (decerebrate), 1 none",
      "GCS ≤8 often used as threshold for intubation to protect airway (with clinical context)",
      "Best eye, verbal, and motor response in each category — use non-dominant side if asymmetric",
    ],
    boardsPearls: [
      "GCS 3 = minimum (no response in all categories); 15 = normal",
      "Decorticate posturing (abnormal flexion) — motor score 3; decerebrate extension — motor score 2",
      "Severe TBI often GCS ≤8; moderate 9–12; mild 13–15 (definitions vary slightly)",
      "Intubated/sedated patients — record 'T' for untestable verbal component; use motor and eye primarily",
      "vs AVPU — simpler alert/voice/pain/unresponsive scale; GCS more granular",
      "Pupillary and motor asymmetry add prognostic information beyond GCS alone",
    ],
    pediatrics:
      "Pediatric GCS uses modified verbal/motor criteria in infants; infants may have lower baseline irritability scores — trend over time matters as much as single value.",
  },
  {
    id: "antiplatelet-therapy",
    name: "Antiplatelet Therapy",
    etymology: "anti- = against + platelet = small plate + Greek therapeia = healing/treatment",
    aliases: [
      "antiplatelet therapy",
      "antiplatelet therapies",
      "antiplatelet treatment",
      "antiplatelet agent",
      "antiplatelet agents",
      "antiplatelet drugs",
      "platelet inhibition therapy",
      "dual antiplatelet therapy",
      "dapt",
    ],
    definition:
      "Pharmacologic inhibition of platelet activation and aggregation to prevent arterial thrombosis — cornerstone of secondary prevention after MI, ischemic stroke/TIA, and peripheral artery disease, and essential with coronary stenting.",
    details: [
      "Aspirin — irreversible COX-1 inhibition → ↓ thromboxane A₂; low-dose daily for most indications",
      "P2Y12 inhibitors (clopidogrel, prasugrel, ticagrelor) — block ADP-mediated platelet activation",
      "Glycoprotein IIb/IIIa inhibitors (abciximab, eptifibatide, tirofiban) — block final common aggregation pathway; IV use in high-risk ACS/PCI",
      "Dual antiplatelet therapy (DAPT) — aspirin + P2Y12 inhibitor for ACS, post-PCI, and high-risk TIA/minor stroke (short course)",
      "Dipyridamole + aspirin — secondary stroke prevention (ESPS2 framework)",
      "Duration individualized: lifelong aspirin for most secondary prevention; DAPT duration depends on stent type and bleeding risk",
    ],
    boardsPearls: [
      "Arterial thrombosis → antiplatelet; venous thromboembolism → anticoagulation (heparin/warfarin/DOAC)",
      "ACS/PCI — DAPT (aspirin + P2Y12 inhibitor); ticagrelor/prasugrel more potent than clopidogrel",
      "Ischemic stroke/TIA — aspirin; short-term DAPT for high-risk TIA or minor stroke",
      "Carotid stenosis, PAD, CAD — long-term aspirin (or clopidogrel if aspirin intolerant)",
      "Clopidogrel is a prodrug — CYP2C19 poor metabolizers have reduced effect",
      "Bleeding is primary risk — GI bleed, intracranial hemorrhage; avoid with active bleeding",
      "Aspirin contraindicated in children with viral febrile illness (Reye syndrome)",
      "vs anticoagulation — antiplatelet for platelet-rich arterial clots; anticoagulation for fibrin-rich venous/LA clots",
    ],
    pediatrics:
      "Aspirin avoided for fever in children (Reye syndrome); aspirin used in Kawasaki disease with IVIG. Pediatric stroke secondary prevention is specialist-guided — antiplatelet therapy may be used but differs from adult DAPT protocols.",
  },
];

const strategyById = new Map(
  CLINICAL_STRATEGIES.map((entry) => [entry.id, entry]),
);

export function getClinicalStrategyById(
  id: string,
): ClinicalStrategyEntry | undefined {
  return strategyById.get(id);
}

export interface ClinicalStrategyAliasMatch {
  alias: string;
  clinicalStrategyId: string;
}

export function buildClinicalStrategyAliasIndex(): ClinicalStrategyAliasMatch[] {
  const matches: ClinicalStrategyAliasMatch[] = [];
  for (const entry of CLINICAL_STRATEGIES) {
    for (const alias of entry.aliases) {
      matches.push({
        alias: alias.toLowerCase(),
        clinicalStrategyId: entry.id,
      });
    }
  }
  return matches.sort((a, b) => b.alias.length - a.alias.length);
}
